We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study.
- Authors
Sherman, Gilad; Lamb, Gabriella S; Sharma, Tanvi S; Lloyd, Elizabeth C; Nagel, Jerod; Dandam, Nada N; Oliveira, Carlos R; Sheikha, Hassan S; Anosike, Brenda I; Lee, Philip; Vora, Surabhi B; Patel, Karisma; Sue, Paul K; Rubbab, Beenish; Yarbrough, April M; Ganapathi, Lakshmi; Nakamura, Mari M
- Abstract
Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.
- Subjects
THERAPEUTIC use of monoclonal antibodies; RESEARCH; COVID-19; CHILDREN'S hospitals; RETROSPECTIVE studies; ACQUISITION of data; RISK assessment; TREATMENT effectiveness; COMPARATIVE studies; SOCIOECONOMIC factors; MEDICAL records; QUESTIONNAIRES; DESCRIPTIVE statistics; RESEARCH funding; DATA analysis software; SOCIODEMOGRAPHIC factors; POLYMERASE chain reaction; LONGITUDINAL method; CHILDREN
- Publication
Journal of the Pediatric Infectious Diseases Society, 2023, Vol 12, Issue 3, p152
- ISSN
2048-7193
- Publication type
Article
- DOI
10.1093/jpids/piac124